Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.

English

Regional settings

Entity•Capital Com UK LimitedAuthorised and regulated by the Financial Conduct Authority (FCA)

My account

Home Markets SharesLoncar Cancer Immunotherapy ETF

Trade Loncar Cancer Immunotherapy ETF - CNCR CFD

Summary Historical Data

Trading Conditions

Spread

0.18

Long position overnight fee

Long position overnight fee

Margin. Your investment	$1,000.00
Overnight fee Charges from full value of position	-0.026179 % (-$1.05)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00

Go to platform

-0.026179%

Short position overnight fee

Short position overnight fee

Margin. Your investment	$1,000.00
Overnight fee Charges from full value of position	0.003957 % ($0.16)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00

Go to platform

0.003957%

Overnight fee time

21:00 (UTC)

Currency

USD

Min traded quantity

Margin

Stock exchange

United States of America

Commission on trade¹

¹Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats

Prev. Close	14.97
Open	14.75
1-Year Change	17.16%
Day's Range	14.7 - 14.95

Loncar Cancer Immunotherapy ETF Company profile

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index.